RRN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.518600E-01
Normal-vs-Stage2
8.083200E-01
Normal-vs-Stage3
1.246230E-01
Normal-vs-Stage4
7.366200E-01
Stage1-vs-Stage2
5.003400E-01
Stage1-vs-Stage3
1.203600E-02
Stage1-vs-Stage4
7.814600E-01
Stage2-vs-Stage3
2.536400E-02
Stage2-vs-Stage4
3.991000E-01
Stage3-vs-Stage4
1.000280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.422400E-01
Normal-vs-AfricanAmerican
7.219000E-01
Normal-vs-Asian
6.647400E-01
Caucasian-vs-AfricanAmerican
1.965200E-01
Caucasian-vs-Asian
6.393400E-01
AfricanAmerican-vs-Asian
2.704800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.260600E-01
Normal-vs-Female
8.499000E-01
Male-vs-Female
5.552600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.545000E-01
Normal-vs-Age(41-60Yrs)
8.958400E-01
Normal-vs-Age(61-80Yrs)
6.464000E-01
Normal-vs-Age(81-100Yrs)
6.233200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.716800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.565800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.917000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.479700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.097800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.039200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.291600E-01
Normal-vs-Daily Drinker
6.966400E-01
Normal-vs-Weekly Drinker
6.243000E-01
Normal-vs-Occasional Drinker
9.907600E-01
Normal-vs-Social Drinker
7.652000E-01
Non Drinker-vs-Daily Drinker
7.781600E-01
Non Drinker-vs-Weekly Drinker
9.517800E-01
Non Drinker-vs-Occasional Drinker
2.168200E-01
Non Drinker-vs-Social Drinker
4.772800E-01
Daily Drinker-vs-Weekly Drinker
8.697600E-01
Daily Drinker-vs-Occasional Drinker
4.312000E-01
Daily Drinker-vs-Social Drinker
7.338400E-01
Weekly Drinker-vs-Occasional Drinker
3.623800E-01
Weekly Drinker-vs-Social Drinker
6.032000E-01
Occasional Drinker-vs-Social Drinker
6.229000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.750370E-02
Normal-vs-Grade 2
3.075700E-03
Normal-vs-Grade 3
4.175600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.309630E-01
Grade 1-vs-Grade 3
5.900400E-02
Grade 1-vs-Grade 4
1.750370E-02
Grade 2-vs-Grade 3
4.195600E-01
Grade 2-vs-Grade 4
3.075700E-03
Grade 3-vs-Grade 4
4.175600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.953600E-01
Normal-vs-NonDiabetic
7.629600E-01
Diabetic-vs-NonDiabetic
2.213400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.187600E-01
Normal-vs-NoPancreatitis
6.954000E-01
Pancreatitis-vs-NoPancreatitis
5.974800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.913400E-01
Normal-vs-N1
8.417000E-01
N0-vs-N1
5.305000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.515400E-01
Normal-vs-TP53-NonMutant
7.125200E-01
TP53-Mutant-vs-TP53-NonMutant
5.975900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
